Newstral
Article
BBC on 2021-02-02 16:16
Pfizer expects $15bn sales of Covid-19 vaccine
Related news
- [Ticker] Pfizer expects €22bn in vaccine sales this yeareuobserver.com
- BPfizer Expects $26B in Covid-19 Vaccine Sales This Yearbarrons.com
- Pfizer expects $20b in COVID-19 vaccine revenue this yearSydney Morning Herald
- FPfizer expects $15bn in Covid vaccine revenue this yearft.com
- Pfizer records $22bn COVID-19 vaccine sales in 2021punchng.com
- HPfizer Raises 2021 COVID-19 Vaccine Sales Forecast to $33.5Bhamodia.com
- Pfizer expects Covid vaccine demand for yearsBBC
- BBioNTech Expects $11.5 Billion in Covid-19 Vaccine Revenuebarrons.com
- Pfizer, BioNTech seek COVID-19 vaccine approval in EuropeNew York Post
- Pfizer reduces ultra-cold requirements for its COVID-19 vaccinenewatlas.com
- APfizer COVID-19 vaccine candidate one step closer to approvalasianjournal.ca
- COVID-19 vaccine 95% effective, Pfizer seeking clearance in daysreviewjournal.com
- How Pfizer Will Distribute Its Covid-19 VaccineThe New York Times
- Pfizer says its COVID-19 vaccine protects younger teensstaradvertiser.com
- Pfizer says its COVID-19 vaccine protects younger teenagersSydney Morning Herald
- Pfizer expects $26 billion in 2021 sales from COVID vaccineNew York Post
- Pfizer sees COVID-19 vaccine, therapeutic sales topping $50 billion in 2022timesofisrael.com
- Vaccine sales power Pfizer through first quarterSeattle Times
- Pfizer to request emergency FDA approval for its COVID-19 vaccineNew York Post
- Pfizer says COVID-19 vaccine is 95% effective, safe for seniorspressherald.com